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Immature neural cell lines could be productively infected by HIV-1. Interestingly, this infection was associated with a
differentiation to a mature neuronal phenotype, characterized by the expression of mature neurofilaments and cell adhesion
molecules, intercellular cell adhesion molecule-1, and vascular cell adhesion molecule-1. Infection also induced TNF-a and
IL-1b mRNA expression, as well as the synthesis of inducible nitric oxide synthase by neuroblastoma cells. Exogenous
addition of TNF-a, but not of IL-1b or many other cytokines, including nerve growth factor, mimicked those effects induced
by infection. Moreover, blocking endogenous TNF-a or NO production in cultures of infected cells with a neutralizing
anti-TNF-a antibody or inducible nitric oxide synthase inhibitors prevented the expression of the mature cell phenotype as
well as expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1. Addition of NO generators
and TNF-a activated NF-kB- and intercellular cell adhesion molecule-1-dependent promoter transcription, whereas inducible
nitric oxide synthase inhibitors prevented the transcriptional activation of intercellular cell adhesion molecule-1 promoter
that was induced by TNF-a. Those results suggest that HIV can infect immature neural cells and this infection induces their
neural development via a TNF-a- and NO-mediated mechanism. © 1999 Academic Press
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HIV-1 infection is often associated with a remarkable
rray of neurological symptoms, such as demyelinating
europathies, meningitis, and vacuolar myelopathy pe-
ipheral nervous system vasculitis, even in the early
symptomatic phases (reviewed in Glass and Johnson,
996; Kolson et al., 1998). Among those, the AIDS demen-
ia complex (ADC) is the most abundant. Its pediatric
ounterpart, commonly called HIV encephalopathy (Bel-
an, 1994), can often be the only clinical manifestation of
IDS in children. Around 30% of adults and 50% of chil-
ren have neurological impairment due to HIV-1 infection
f the central nervous system (CNS). At least 90% of
IDS patients demonstrate neuropathological abnormal-
ties at autopsy (Janssen et al., 1989). Those neuropatho-
ogical hallmarks have been well described, consisting
f encephalitis, reactive microglial cells, infiltration of
acrophages, and widespread astrocytosis (Glass and
ohnson, 1996). Neuropathological changes also include
orphological alteration and even destruction of cortical
nd basal ganglia neurons (Masliah et al., 1996).
However, the pathogenic mechanisms of neurological
lteration in HIV-infected individuals are yet a matter of
1 To whom correspondence and reprint requests should be ad-
ressed at Hospital General Universitario Gregorio Maran˜on, Servicio
e Inmunologia, c/Dr. Esquerdo 47, 28007 Madrid, Spain. Fax: 34-91-b868018. E-mail Mmunoz@cbm.uam.es.
193ebate. In particular, it is unclear whether the functional
mpairment is due to a direct (virus infection) or indirect
immune activation) mechanism or both. Recent results
ave indicated that viral load of the CNS correlates with
eurological symptoms (Cinque et al., 1998; Stefano et
l., 1997). In addition, there is a good correlation in the
ost severe cases of disease with markers of immune
ctivation, such as cytokines, especially TNF-a (Dubois-
alcq et al., 1995). TNF-a but not IL-1 or IL-6 mRNA levels
re augmented in the brains of ADC patients (Glass and
ohnson, 1996; Wesselingh et al., 1994). Moreover, TNF-a
evels are elevated in the CSF and serum of AIDS pa-
ients and those levels are closely correlated with the
everity of dementia (Dubois-Dalcq et al., 1995; Wessel-
ngh et al., 1994). Expression of cell adhesion molecules
CAM) is also up-regulated coincidentally with TNF-a
Obrego´n et al., 1996).
According to several authors, clinical manifestations
uch as neuronal cell loss correlate with macrophage
nfiltration (Brew et al., 1995) and initial studies sug-
ested that infiltrating mononuclear phagocytes were the
ajor HIV-1-infected cells in the brain (Koenig et al.,
986). However, this hypothesis does not explain the
resence of the virus in the brain before any sign of
nflammation (An and Scaravilli, 1997). Recent studies
ave demonstrated that direct infection of the neuronal,
stroglial, and microglial elements of the brain takes
lace in HIV-1-associated dementia. Viral particles have
een observed in astrocytes from pediatric AIDS patients
0042-6822/99 $30.00
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194 OBREGO´N ET AL.Epstein et al., 1985). Besides, HIV-1-infected neurons
ave also been described in the brain from AIDS patients
Budka, 1989; Nuovo et al., 1994; Saito et al., 1994) and
rimary human neuroblasts (Ensoli et al., 1995) as well
s neuronal cell lines can be infected by HIV-1 in vitro
Ensoli et al., 1994; Harouse et al., 1989; Li et al., 1990;
izrachi et al., 1994). On the other hand, certain viral
roducts can be neurotoxic. Among those, the external
p120 glycoprotein is the most likely candidate, although
egulatory proteins, such as Tat, have also been involved
Price, 1996). They may exert neurotoxicity to neurons
ither directly or indirectly through neurotoxic mediators,
uch as nitric oxide (NO) and TNF-a (An and Scaravilli,
997; Chen et al., 1997; Gelbard et al., 1994; Power et al.,
995).
NO influences many aspects of CNS physiology, in-
luding synaptic plasticity, neuronal development, and
ehavioral responses (reviewed in Bredt and Snyder,
994; Mun˜oz-Ferna´ndez and Fresno, 1998). Moreover, a
athological role of NO in the CNS is also evident (Bredt
nd Snyder, 1994; Mun˜oz-Ferna´ndez and Fresno, 1998).
O is synthesized from L-arginine by the NADPH-depen-
ent enzyme NO synthase (NOS), of which there are
hree types (reviewed in Knowles and Mocada, 1994;
athan and Xie, 1994). Isoform I, or nNOS, is Ca21-
ependent and it is constitutively present in neuronal
nd certain epithelial cells. Isoform III, or eNOS, ex-
ressed in endothelial cells, is also Ca21-dependent. In
ontrast, isoform II, or iNOS, is Ca21-independent and is
nducible by lipopolysaccharide and cytokines, requiring
ctivation of the gene and de novo synthesis of iNOS
rotein. It is now clear that NOS isoforms are not con-
ined to separate cell lineages, but they may coexist in
he same cell type. Besides, recent results have shown
n increase in the expression of iNOS mRNA and protein
n the brains of severe ADC patients and pediatric pa-
ients with advanced HIV encephalitis, which correlated
ith the severity of the disease (Adamson et al., 1996;
ukrinsky et al., 1995).
We have shown here that HIV-1 infection promotes dif-
erentiation of human neuroblastoma (NB) cells, as de-
ected by the induced expression of intercellular cell adhe-
ion molecule (ICAM)-1 and vascular cell adhesion mole-
ule (VCAM)-1 as well as mature neurofilament protein
NFP) expression. Moreover, those cells chronically in-
ected with HIV-1 synthesize IL-1 and TNF-a as well as
NOS. Interestingly, this HIV-1-induced NB differentiation is
ontrolled by the autocrine production of TNF-a and NO.
RESULTS
nfection of neuroblastoma cells by HIV-1
Although neuronal cell lines can be infected in vitro by
IV-1 and infected neurons are detected in vivo, very
ittle is known about the effect of viral infection on the
ost cells. To study this, tumor cell lines of neuronal frigin, SK-N-SH and SK-N-MC, representing immature
ifferentiation stages (Gross et al., 1992), were infected
ith primary and established HIV-1 isolates at a low
.o.i. (0.03) and viral replication was assessed after
nfection by monitoring p24 viral core antigen production
n the cell supernatants at serial time points. A represen-
ative experiment is shown in Fig. 1. Both cell lines were
roductively infected by HIV-1, as shown by increasing
gp24 levels in the culture supernatants with time (Fig.
A). Moreover, HIV-1 DNA was detected by nested PCR
n HIV-1-infected SK-N-SH and SK-N-MC cells (Fig. 1B).
ell viability was not altered after infection, did not
hange with time, and was always greater than 95% for
oth cell lines (data not shown). Infection of NB with a
igher m.o.i. resulted in a dose response increase in the
mount of Agp24 released to the supernatant (data not
hown). Between 35 and 50% (depending on the exper-
ment) of the NB cells were infected, as detected by
nfection with recombinant HIV-1-GFP (expressing green
luorescence protein) (data not shown), in agreement
ith previously published data on the same NB (Vesanen
t al., 1992). Although only performed with four strains, it
eemed that viruses with a SI/RH phenotype were much
ore infectious than those of NSI/SL.
To further confirm that in HIV-infected NB cell lines the
gp24 detected represent infectious virus, the highly
ensitive MT-2 cell line was cocultured with supernatant
FIG. 1. Infection of NB cell lines by different HIV-1 isolates. SK-N-MC
r SK-N-SH NB cells were infected with (0.03 m.o.i.) of the primary
solates HIVLRH, HIVCGP, HIVFGA, as well as with the established strain
IVpNL4.3 or mock infected with heat-inactivated pNL434 (10 m.o.i.). (A)
gp24 was quantified in the supernatants of cultures 0, 3, 6, and 12
ays after infection. (B) At 12 days after infection HIV-1 viral DNA was
etected in the cell cultures by a nested PCR of the pol region of HIV.
anes 1–4, NB infected with HIVLRM, HIVCGP, HIVFCD, and HIVpNL43, re-
pectively; lane 5, mock-infected cells; and lane 6, positive control of an
nfected T cell line.rom NB-infected cells, harvested 3 days after infection,
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195HIV INDUCES NEURONAL DIFFERENTIATION VIA TNF AND iNOSnd tested again for productive infection. As seen in Fig.
A, high levels of Agp24, which increased over time,
ere again detected in those cultures, suggesting that
nfectious virus is produced by NB cells. Moreover, syn-
ytia formation was also detected in MT-2 cultures (Fig.
B). Taken together the above findings suggest that pro-
uctive infection can take place in these neuronal cell
ines and that infection is not limited to one particular
train of HIV-1.
ffect of HIV-1 infection on neuronal phenotype
To study the effect of HIV infection on cell differentia-
ion, NB cells were infected with HIV and differentiation
as monitored 72 h postinfection through expression on
he cell surface of adhesion molecules (ICAM-1 and
CAM-1) by flow cytometry. The higher expression of
hose CAM is directly related to a more differentiated
henotype (Gross et al., 1992). The results of a represen-
ative example are shown in Fig. 3. Infection of SK-N-SH
nd SK-N-MC human NB lines strongly up-regulated the
xpression of both cell adhesion molecules, ICAM-1 and
CAM-1, at the cell surface. Thus, 3 days after infection
FIG. 2. Infection of MT-2 cell line with culture supernatants from HIV-
g Agp24/ml/105 cells) from SK-N-SH or SK-N-MC infected with pNL4.3 s
horoughly and 0, 3, 6, and 12 days later, virus production was quantifie
nfection. Panel (1), culture supernatants from SK-N-SH; (2), supernatalmost all NB cells expressed ICAM-1 compared to nround 40% in uninfected cultures. VCAM-1 expression
ncreased from 15–20% to 40–70%. Moreover, the mean
luorescence intensity of positive cells was also strongly
ncreased.
The induction of a differentiation phenotype of NB
ells by HIV infection was also evaluated by indirect
mmunofluorescence assay using monoclonal antibod-
es specific to mature NFPs of neurons and neuroblasts,
2 h after HIV-1 infection. Changes in the type and
mount of intermediate NFP have been shown to asso-
iate with neuronal differentiation (Biedler et al., 1988;
iem et al., 1978; Shaw and Weber, 1982). No significant
hanges were observed after infection in the fluores-
ence with the 68-kDa NFP, which is expressed in im-
ature and mature neural cells (Fig. 4). By contrast, the
xpression of 200-kDa NFP, expressed mainly by mature
ells, was significantly more pronounced in NB after
nfection with HIV-1 (compare Figs. 4e and 4f). It is
oteworthy that a shift in fluorescence localization from a
iffuse somatic to an intense perinuclear pattern was
bserved in HIV-1-infected NB with both antibodies. In
ddition, much of the fluorescence was also localized in
ted NB cell lines. MT-2 cell line was incubated with supernatants (200
arvested 12 days after infection. (A) After 24 h, MT-2 cells were washed
asuring Agp24 in the supernatant. (B) Syncytia formation 10 days after
SK-N-MC; and (3), with infectious HIVpNL43 virus.1-infec
train h
d by meeuritic processes in differentiated cells (Fig. 4).
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196 OBREGO´N ET AL.ole of TNF-a and NO in HIV-induced neuroblastoma
ifferentiation
It has previously been shown that some cytokines are
xcellent inducers of ICAM-1 and VCAM-1 (Springer,
995). Thus we tested the effect of exogenously added
ytokines to uninfected SK-N-SH cells in order to see if
hey could mimic induction of cell adhesion molecules
nduced by HIV-1 infection. Of all cytokines tested only
NF-a was able to upregulate ICAM-1 and VCAM-1 (Ta-
le 1). Surprisingly, IL-1b, which was effective on induc-
ng CAM in other cell types (Springer, 1995), had no
ffect. Similar results were obtained with SK-N-MC (data
ot shown). Since only TNF-a induced the expression of
CAM-1 and VCAM-1 in NB cells, we investigated the
ossibility that HIV-1 infection in NB caused TNF-a syn-
FIG. 3. Induction of ICAM-1 and VCAM-1 expression by HIV-1 infect
.1 m.o.i. of HIVpNL4.3 as described under Materials and Methods. Th
CAM-1-specific monoclonal antibodies or with an isotype-matched i
hown inside the panels are the percentage of positive cells with reshesis, which in turn mediated differentiation of SK-N-MC ind SK-N-SH by an autocrine/paracrine mechanism. Re-
ults in Fig. 5 indicated that HIV-1 infection augmented
NF-a mRNA in NB cells. IL-1b mRNA was, however,
nduced by HIV-1 infection (Fig. 5).
Previously we have shown that NO was involved in
NF-a-induced NB differentiation (Obrego´n et al., 1997).
herefore, we examined if this mechanism was also
aking place during NB differentiation induced by HIV-1
nfection. For this, we assayed the NOS enzymatic activ-
ty in human NB 72 h postinfection, as determined by
easuring the conversion of L-[3H]arginine to L-[3H]citrul-
ine by a dialyzed cytosolic fraction. NOS activity was not
etectable in the cytosol of uninfected NB cells even
hough Ca21 was added to the reaction mixture (Fig. 6).
owever, Ca21-independent NOS activity was detected
B cells. SK-N-SH and SK-N-MC were infected or mock infected with
ys after infection, cells were collected and stained with ICAM-1- or
t antibody. Cell surface expression was detected by flow cytometry.
the irrelevant isotype matched (control) monoclonal antibody.ion in N
ree da
rrelevann infected NB. Thus, HIV-1 infection induces in NB cells
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197HIV INDUCES NEURONAL DIFFERENTIATION VIA TNF AND iNOSCa21-independent NOS comparable to the inducible
orm of activated macrophages or hepatocytes (Kowles
nd Mocada, 1994).
iNOS expression in HIV-1-infected NB was confirmed
y using RT–PCR with specific primers to detect iNOS
RNA. Uninfected SK-N-SH or SK-N-MC cells did not
how any specific product amplified. When those unin-
ected cells were treated with exogenous TNF-a, a
nown inducer of iNOS (Nathan and Xie, 1994), an iNOS-
pecific amplification product of 259 bp was detected.
hen the cells were infected with HIV, the RT–PCR of
FIG. 4. Induction of mature neurofilament expression by HIV-1 infec-
ion in NB cells. SK-N-SM and SK-N-MC were mock infected (a, e) or
nfected with HIVpNL4.3 strain (0.1 m.o.i) in the absence (b, f) or in the
resence of (c, g) anti-TNF-a or (d, h) L-NIL. Three days after infection
ells were stained with monoclonal antibody against 68-kDa NFP (a–d)
r with a polyclonal antibody against 200-kDa NFP (e–h). A represen-
ative optical field is shown.solated mRNA also resulted in an iNOS-specific ampli- fication product of 259 bp (Fig. 7). Thus, the differentia-
ion of infected SK-N-MC and SK-N-SH was accompa-
ied by expression of iNOS mRNA. Interestingly, this
ffect was completely blocked by addition of a neutral-
zing anti-TNF-a antibody (Fig. 7), suggesting that iNOS
as induced by a TNF-a autocrine/paracrine mechanism
n these infected NB cells.
Furthermore, the adhesion/differentiation process in-
uced by HIV-1 infection in human NB, detected by cell
urface expression of ICAM-1 in the infected NB cells,
as greatly prevented by the specific iNOS inhibitor, as
ell as by the addition of a neutralizing anti-TNF-a anti-
ody (Fig. 8). Considering the percentage of positive
ells and the mean fluorescence intensity together, both
reatments reduced HIV-1-induced CAM expression by
ore than 90%. The low basal levels of CAM expression
n NB were not affected by L-NIL or anti-TNF-a treatment
data not shown). Similar effects with anti-TNF-a antibody
nd L-NIL were observed in the HIV-1-induced expres-
ion of the 200-kDa NFP (see Fig. 4).
Most of the effects of HIV-1 on NB cells described
bove required a productive viral infection. Thus, treat-
ent of NB cultures with azidothymidine (AZT), which
locks viral replication, prevented in a dose response
anner ICAM-1 and VCAM-1 upregulation, iNOS induc-
ion, as well as recovery of syncytium-inducing infectious
irus from NB supernatants in both SK-N-SH (Table 2)
nd SK-N-MC (data not shown). Furthermore, there was
good correlation between the ability of AZT to block
iral replication and the rest of the effects mentioned.
hose effects were not due to contaminating myco-
lasma or lipopolysaccharide in the viral preparation
ince control heat-inactivated virus, even at a 100-fold
igher m.o.i., induced no up-regulation of ICAM-1 and
CAM-1 (Table 2).
ffect of NO on ICAM-1 transcription
To study the above actions at the molecular level, we
nalyzed the effect of NO and TNF-a in the transcription
ctivity of the ICAM-1 promoter. As shown in Fig. 9, NB
ells had a high level of ICAM-1 basal transcription.
owever, TNF-a induced a dose response increase in
he transcriptional activity of a luciferase plasmid under
ontrol of the ICAM-1 promoter. Interestingly, addition of
he inhibitors of the iNOS, L-NMMA or L-NIL, largely
revented this induction. Moreover, addition of NO gen-
rators, such as SNAP or SNP, significantly increased
CAM-1 transcription, although at a lower level than
NF-a (Fig. 9A). ICAM-1 transcription is strongly depen-
ent on the activation of the NF-kB transcription factor
Baeuerle and Henkel, 1994; Stratowa and Audette,
995). Therefore, we tested the effect of TNF-a and NO in
he transcriptional activity of a luciferase plasmid under
ontrol of the kB binding sites. Similarly to the resultsound with ICAM-1 promoter, NB cells had a high level of
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198 OBREGO´N ET AL.asal transcription. Both TNF-a and NO generators ac-
ivated NF-kB-dependent transcription in NB cells, hav-
ng additive effects. Moreover, the presence of iNOS
nhibitors completely or partially abrogated the induction
f NF-kB activity induced by TNF-a in NB cells (Fig. 9B).
DISCUSSION
The pathogenic mechanisms of neurological alteration
n HIV-infected individuals are yet a matter of debate. In
articular, it is unclear whether the functional impairment
s due to a direct (virus infection) or indirect (immune
ctivation) mechanism or both. HIV-1-infected neurons
ave been described in brain from AIDS patients (Budka,
989; Nuovo et al., 1994; Saito et al., 1994) and primary
uman neuroblasts (Ensoli et al., 1995) can be infected in
itro. Moreover, recent studies have indicated that direct
nfection of the neurons may contribute to HIV-1-associ-
ted dementia. Thus, neurological damage in AIDS and
T
Effect of Cytokines on CAM E
Cytokine added
4 h
ICAM-1 VCAM-1
None 20 7
TNF-a 36 20
IFN-g 18 7
IL-6 21 8
IL-4 19 10
IL-10 21 8
IL-1b 21 9
Note. SK-N-MC cells were incubated with 100 U/ml of the indicated
tained with ICAM-1- or VCAM-1-specific monoclonal antibodies or with
y flow cytometry.
FIG. 5. Induction of TNF-a and IL-1b by HIV-1 infection in NB cells.
K-N-MC (lanes 1 and 4), SN-N-SH (lanes 2 and 5), as well as the
lioma U-87 (lanes 3 and 6), used as a control, were mock infected with
IV (lanes 1–3) or infected with HIVpNL4.3 strain (0.1 m.o.i) (lanes 4–6). (A)
L-1b mRNA and (B) TNF-a mRNA were analyzed by RT–PCR. Lanes 7,
egative controls, and lanes 8, positive controls with mRNA of IL-1b or
NF-a, respectively. Rlinical severity correlated with the percentage of neu-
ons infected (Bukrinsky et al., 1995). In favor of a direct
nfection of neurons is the fact that LTR-driven HIV-1
ranscription may take place in neurons but not in astro-
ytes of LTR transgenic mice, suggesting that developing
eurons are fully competent to support HIV-1 replication
Buzy et al., 1995). Furthermore, transgenic mice ex-
ressing a full HIV-1 genome in neurons underwent
xonal degeneration even in the absence of detectable
iral proteins (Thomas et al., 1994), suggesting that re-
tricted expression of the HIV-1 genome may cause
egeneration. Thus, direct neurological infection may
lso contribute to the neurological dysfunction.
All these results have raised important questions as to
he potential role of restricted neuronal infection in the
nduction of neuronal cell death and/or cellular dysfunc-
ion in ADC. We have tried to address some of those
uestions using cell lines established from several NBs,
ion by Neuroblastoma Cells
12 h 24 h
M-1 VCAM-1 ICAM-1 VCAM-1
1 6 23 9
8 23 46 27
2 6 20 10
2 8 22 10
3 10 20 11
0 10 20 8
9 9 22 9
es for 24 h. After 4, 12, or 24 h of incubation, cells were collected and
ype-matched irrelevant antibody. Cell surface expression was detected
FIG. 6. Induction of iNOS enzymatic activity by HIV-1 infection in NB
ells. SK-N-SH and SK-N-MC were mock infected or infected with
IVpNL4.3 strain (0.1 m.o.i.). Infected cells were also treated with TNF-a
300 U/ml). After 3 days, cells were lysed and NOS activity was deter-
ined by conversion of L-[3H]arginine to L-[3H]citrulline in the cytosolic
raction in the presence or the absence of exogenous added Ca21.ABLE 1
xpress
ICA
2
3
2
2
2
2
1
cytokin
an isotesult shown are the mean 6 SEM of two different experiments.
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RT–PCR with specific primers. Lane 5, positive control.
H
l
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VCAM-1, whereas SK-N-MC had 41% for ICAM-1 and 22% for VCAM-1.
199HIV INDUCES NEURONAL DIFFERENTIATION VIA TNF AND iNOSikely representing the in vivo differentiated neuronal
tages, providing a useful model for analysis of NB
henotypic differentiation (Gross et al., 1992). SK-N-SH
nd SK-N-MC human NB lines are relatively undifferen-
iated cells that can be induced to differentiate toward
euroblasts or Schwannlike mesoectodermal cells by a
ariety of stimuli (Biedler et al., 1988). Our results indicate
hat those neuronal cell lines can be productively in-
ected by HIV-1, in agreement with previous results in
ther NB cells (Ensoli et al., 1994; Harouse et al., 1989; Li
t al., 1990; Mizrachi et al., 1994). This was independent
f the viral phenotype of the infective virus. However, the
evel of viral replication was low and did not kill NB cells,
uggestive of a chronic restricted viral replication. HIV-1
nfectivity was associated with an immature phenotype
f the NB cells. This is in agreement with previous
-TNF-a and iNOS inhibitors. SK-N-MC and SK-N-SH were infected with
eutralizing anti-TNF-a antibody or the iNOS inhibitor L-NIL. Three days
3. The percentages of positive cells with respect to an irrelevant
SK-N-SH cell cultures had 45% positive cells for ICAM-1 and 21% forFIG. 7. Induction of iNOS mRNA by HIV-1 infection in NB cells.
K-N-SH (A) and SK-N-MC (B) were mock infected (lane 1), treated with
NF-a (300 U/ml) (lane 2), infected with HIVpNL4.3 strain (0.1 m.o.i.) (lane
), or HIV-1 infected in the presence of a neutralizing anti-TNF-a
ntibody (lane 4). Three days later, iNOS mRNA was detected byFIG. 8. Prevention of HIV-1-induced ICAM-1 and VCAM-1 expression by anti
IV-1 (HIVpNL4.3 strain, 0.1 m.o.i.) in the absence (control) or in the presence of n
ater cell surface expression was evaluated by flow cytometry as in Fig.
sotype-matched monoclonal antibody are shown inside the panel. Uninfected
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200 OBREGO´N ET AL.esults showing that immature neurons as well as fetal
strocytes are more susceptible to HIV-1 infection (En-
oli et al., 1995; Tornatore et al., 1994; Truckenmiller et al.,
993; Vesanen et al., 1994), suggesting that the immature
lements of the developing nervous systems are more
usceptible to HIV-1 infection.
Interestingly, our results indicate that HIV-1 infection
nduces differentiation of human NB cells, measured by
AM and mature NFP expression. HIV infection also
nduced iNOS mRNA, although this was mediated by an
utocrine/paracrine TNF-a mechanism. Those effects re-
uire productive HIV-1 replication in NB cells. Moreover,
ur results suggest that HIV-1 infection increases TNF-a,
lthough this cannot be accurately quantified by the
T–PCR technique and induces IL-1b synthesis. The
roduction of TNF-a by HIV-1 infection has been previ-
usly described in several hematopoietic cell lines
Fauci, 1996). More importantly, NB differentiation was
lso controlled by the autocrine production of TNF-a via
he production of NO production. Similar to what we
ound in NB, in human macrophages HIV-1 infection
nduced iNOS expression (Bukrinsky et al., 1995). More-
ver, a direct correlation between endogenous NO pro-
uction and viral replication was found (Bukrinsky et al.,
995).
Recent results have shown an increase in the expres-
ion of iNOS mRNA and protein in the brains of severe
DC patients and pediatric patients with advanced HIV
ncephalitis (Adamson et al., 1996; Bukrinsky et al.,
995). These results indicate that HIV-1 can induce the
xpression of iNOS in vivo. This enhanced iNOS can be
ue to direct infection by HIV-1 or mediated by HIV-1
nvelope proteins (gp160 or gp41), either directly or in-
irectly through TNF-a induction. Neurons may be in-
uced to up-regulate NO production by HIV gp120
Power et al., 1995). Furthermore, gp41 induces iNOS in
rimary cultures of mixed rat neuronal and glial cells
T
The Effects of HIV-1 on NB Cel
Virus addition
Agp24
formation ICAM-1 expression
one 0 21 6 4
NL 123 6 16 83 6 12 (p , .005)
NL (AZT 10) 78 6 8 59 6 8 (p , .01)
NL (AZT 25) 7 6 3 32 6 8 (ns)
NL (hi) 0 24 6 3 (ns)
Note. SK-N-MC or SK-N-SH NB cells were infected with the indicate
r mock infected with heat-inactivated virus (hi). AZT at 25 or 10 mg/ml
ere collected and stained by flow cytometry. with ICAM-1 and VCAM-
ith respect to the irrelevant isotype-matched monoclonal antibody of tw
f NB at day 3 postinfection. Syncytia formation was measured in MT-2
mount is indicated by a plus or minus sign). iNOS induction was mea
r the absence of an amplified specific band in the gel is indicated byABLE 2
ls Are Dependent on Viral Replication
VCAM-1
expression
Syncytia
formation
iNOS
induction
17 6 3 2 2
39 6 4 (p , .001) 111 1
30 6 2 (p , .01) 11 1
21 6 3 (ns) 2 2
23 6 2 (ns) 2 2
d amount of the primary isolate HIVLRH or with the established strain HIVpNL4.3
was added to the cultures where indicated. Three days after infection, cells
1 monoclonal antibodies. The percentages of the mean positive cells 6 SEM
o different experiments are shown. Agp24 was measured in the supernatants
cells using supernatants of NB cultures 3 days after infection (their relative
sured by RT–PCR as described under Materials and Methods. The presenceAdamson et al., 1996). However, we think that this mech- RFIG. 9. Activation of ICAM-1- and NF-kB-dependent transcription by
NF-a and NO. (A) ICAM-1 promoter. SK-N-SH cells were transfected
ith a reporter plasmid having luciferase under the control of the 1.3-kb
pstream region of the human ICAM-1 promoter. (B) NF-kB-dependent
ranscription. SK-N-SH cells were transfected with a reporter plasmid
aving luciferase under the control of three kB sites. After transfection,
ells were incubated with TNF-a (300 U/ml), SNAP (25 mM), SNP (30
M) L-NIL (200 mM), and L-NMMA (200 mM) alone or in combination
here indicated. Four hours later luciferase activity was determined.
esults shown are the mean 6 SEM of two different experiments.
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201HIV INDUCES NEURONAL DIFFERENTIATION VIA TNF AND iNOSnism, involving viral proteins such as gp 120 and/or
p41, is unlikely to take place in our system since heat-
nactivated virus even at high concentrations did not
p-regulate iNOS or ICAM-1.
Until very recently NO production by neuronal cells
as thought to be constitutive in response to neurotrans-
itters (Knowles and Mocada, 1994; Nathan and Xie,
994). However, several recent results clearly show that
eurones can express iNOS in vitro and in vivo in patho-
hysiological circumstances (Kifle et al., 1996; Obrego´n
t al., 1997; Ogura and Esumi, 1996; Peunova et al., 1996).
ur present results confirm previous reports that sug-
ested a physiologic role for iNOS-derived NO in neural
ifferentiation (Obrego´n et al., 1997; Peunova and Enikol-
pov, 1995; Peunova et al., 1996). Besides, an increase in
NOS immunoreactivity accompanies regenerative pro-
esses in peripheral ganglia, further suggesting that NO,
he product of iNOS activity, could be involved in nerve
egeneration (Magnusson et al., 1996). Taken together
hose data suggest that iNOS-derived NO may be an
mportant mediator in the induction of neuronal cell dif-
erentiation by certain cytokines.
On the other hand, we have shown here for the first
ime that NO induces ICAM-1 transcription. This takes
lace most likely by activating NF-kB, since it is known
hat ICAM-1 transcription is dependent on NF-kB activa-
ion (Stratowa and Audette, 1995) and basically the same
esults were obtained with NO generators in NF-kB-
ependent transcription. Very interestingly, TNF-a-in-
uced ICAM-1- and NF-kB-dependent transcription were
lmost completely abrogated by blocking iNOS enzy-
atic activity. This suggests that iNOS, besides being a
F-kB-dependent gene (Baeuerle and Henkel, 1994), is
lso a downstream regulator of NF-kB, at least in NB
ells. In agreement with that role, NO has been shown to
odulate NF-kB activity, either positively or negatively
Lander et al., 1993; Peng et al., 1995).
In summary, HIV-1 infection can enhance the produc-
ion of several proinflammatory cytokines, such as
NF-a, which in turn may cause increased iNOS produc-
ion in infected as well as in neighboring uninfected
acrophages, astrocytes, or neurons, altering their func-
ional properties. This NO and TNF-a thus released may
ause the astrocytosis and gliosis often observed in HIV
eurological disease (Glass and Johnson, 1996; Mun˜oz-
erna´ndez and Fresno, 1998) and may contribute not only
o degeneration but also to other neuronal dysfunctions,
ince TNF-a also affects electrophysiological currents on
eurons (Ko¨ller et al., 1997). Furthermore, the secretion of
NF-a by HIV-1-infected neural cells may be involved the
nduction of virus replication in infected cells as well as
n neighboring cells in an autocrine/paracrine manner,
imilar to what takes place in lymphocytes and mono-
ytes (Fauci, 1996; Mun˜oz-Ferna´ndez et al., 1997). Vari-
us mechanisms may thus converge on target neurons,
here differentiation, as well as direct cytopathic effect, Pay lead to cellular dysfunction and cell death, which
ould be responsible for several of the symptoms asso-
iated with AIDS dementia. Moreover, our results open
ew therapeutic possibilities in HIV-1 patients with clin-
cal symptoms of neurologic disease, by using drugs
ble to neutralize iNOS, as has been used for treatment
f autoimmune encephalomyelitis, where TNF-a and
NOS play a central role in pathogenesis.
MATERIALS AND METHODS
aterials
Recombinant human TNF-a was a generous gift of
ntibioticos-Pharma (Madrid, Spain). L-NG-monomethyl-
rginine (L-NMMA), D-NG-monomethylarginine (D-NMMA),
-N6-(1-imidoethyl)lysine (L-NIL), and S-nitroso-N-
cetylpenicillamine (SNAP) were purchased from Alexis
orporation (San Diego, CA). Sodium nitroprusside
SNP) was purchased from Sigma Chemical Co (St.
ouis, MO). Monoclonal antibodies against the 68-kDa
eurofilament protein (NFP) complex (Mouse-Ascite
luid, Clone NR4) and against the 200-kDa NFP (devel-
ped in rabbit, IgG fraction of antiserum) were pur-
hased from Sigma Chemical Co. Anti-human ICAM-1
nd anti-human VCAM-1 monoclonal antibodies were
urchased from Ancell, Immunology Research Products
Bayport, U.S.A.). The neutralizing anti-TNF-a monoclonal
ntibody B13.2 was developed in our laboratory. It does
ot cross-react with lymphotoxin (TNF-b) and it is able to
eutralize the cytotoxic and T cell costimulatory activity
f TNF-a (Pimentel-Muin˜os et al., 1994).
ell lines and virus stocks
The human NB lines SK-N-SH (a generous gift of Dr. F.
a´nchez-Madrid. Hospital de la Princesa, Madrid, Spain)
nd SK-N-MC (from ATCC HTB10) were routinely grown
n RPMI 1640 (Biochrom KG Seromed, Berlin, Germany),
upplemented with 10% heat-inactivated fetal calf serum
FCS), 1% penicillin/streptomycin, and 2 mM L-glutamine
ICN Pharmaceuticals, Costa Mesa, CA) at 37°C in a
umidified atmosphere of 5% CO2.
Three primary HIV-1 isolates (HIV-1LRH, HIV-1CGP, HIV-
FGA), isolated by us from HIV-1-infected patients, and a T
ymphocyte-adapted strain (HIV-1pNL4.3, kindly provided by
r. Alcamı´, Hospital 12 de Octubre, Madrid, Spain) were
sed. The phenotypes of those HIV-1 isolates are differ-
nt. They were classified according to: (a) their syncy-
ium inducing (SI) capacity by cocultivating the patient’s
BMC with MT-2 cells and (b) the replicative capacity in
BMC operatively defined as rapid/high (R/H) or slow/
ow (S/L) (Mun˜oz-Ferna´ndez et al., 1996). Based on that,
he HIV-1 isolates used were HIV-1LRH (SI, R/H), HIV-1CGP
SI, S/L), HIV-1FGA (NSI, S/L), and HIV-1pNL43, (SI, R/H). Virus
tocks were prepared by expanding viral isolates in
BMC and were titrated using the end point dilution
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202 OBREGO´N ET AL.ethod (Ka¨rber, 1931). Briefly, 106 MT-2 cells were in-
ected with the corresponding virus at a m.o.i of 0.1, in a
inal volume of 5 ml of complete medium. After 3–4 days,
hen the cells presented 75% syncytia, 30 3 106 MT-2
ells in 30 ml of complete medium were added to the
ulture and incubated again until 75% of syncytia were
bserved in the culture. The cells were then pelleted at
200 rpm for 10 min. The virus was further purified by
ltracentrifugation (Aoki-Sei et al., 1992) and titrated. The
emaining supernatant was used as a negative control in
he same experiment. Mock infection was also carried
ut with heat-inactivated viral preparations.
IV infection of neuroblastoma cells
SK-N-SH or SK-N-MC cells were exposed to HIV-1, at
ifferent m.o.i. (0.01 to 0.1), depending on the experiment,
or 2 h at 37°C. At the end of this period, the culture
edium was removed, cells were extensively washed
ith PBS, and 3 ml of complete medium was added to
ach well. Virus titers were evaluated in the last washing
uffer (time 0). Cell supernatants were harvested every 3
ays postinfection to monitor p24 viral core antigen pro-
uction using an antigen capture (INNOTEST HIV anti-
en mAb, Innogentic N.V., Belgium). The sensitivity of the
ssay was at least 4 pg/ml. Viral infection in NB was also
etected by polymerase chain reaction (PCR) with a set
f nested primers specific for a region of the pol gene
JA17 to JA20) described previously (Mun˜oz-Ferna´ndez et
l., 1996). Briefly, the samples were first amplified for 24
ycles with the outer primers, and then 0.1 (5 ml) of the
roduct from the first PCR reaction was amplified for 30
ycles with the inner primers. Only samples that gave
ositive signals with primers specific for the human
ousekeeping GAPDH gene were therefore suitable and
sed for amplification. The PCR product was analyzed by
lectrophoresis on 1.5% agarose gels stained with
thidium bromide. In parallel cultures, and at the same
ime after infection, NB cells were removed from the
lates by trypsinization, washed, and counted by trypan
lue dye exclusion. In all experiments, cell viability was
bove 95% for both infected cell lines.
CAM-1 and VCAM-1 expression
The expression of ICAM-1 and VCAM-1 in NB was
valuated by direct flow cytometry as previously de-
cribed (Obrego´n et al., 1997). Briefly, cells (1–2 3 105/
00 ml) were incubated in RPMI supplemented with 10%
CS, in the absence or the presence of different stimuli.
he cells were recovered by treatment of the monolayers
ith 0.02% EDTA in phosphate-buffered saline and
ashed twice in EDTA-containing RPMI medium. They
ere subsequently incubated with fluorescein isothio-
yanate-labeled anti-ICAM-1 and phycoeritrin anti-
CAM-1 monoclonal antibodies or with irrelevant fluo-escein isothiocyanate or phycoerithrin-labeled mono- Tlonal antibodies as negative controls, for 30 min at 4°C.
hen the cells were washed in the above buffer and
urface fluorescence was determined in a FACS-Scan
pectrofluorimeter (Becton–Dickinson). A minimum of
0,000 cells per point were analyzed.
mmunofluorescence analysis
Cell monolayers, infected or mock infected with HIV-1,
ere washed four times with PBS and cultured for 48 h
ith 200 mM L-NIL and 10 mg/ml anti-TNF-a as indicated.
fter the incubations, cells were fixed with methanol for
5 min at 4°C. The coverslips were extensively washed
ith PBS and blocked for 15 min at room temperature
ith 2% bovine serum albumin in PBS. Monoclonal anti-
8-kDa NFP or rabbit IgG against 200-kDa NFP was
dded to the coverslips and incubated 45 min at room
emperature. After washing once with PBS and twice
ith 2% bovine serum albumin in PBS, a second immu-
oglobulin-fluoresceinated rabbit anti-mouse or goat
nti-rabbit-rhodaminated immunoglobulin antibody, re-
pectively, was added and incubated for additional 45
in at room temperature. After being washed four times
ith PBS and once with ethanol, coverslips were
ounted in Moviol (Sigma). The preparations were ex-
mined in a Zeiss Axioskop microscope and photo-
raphed on Kontax.
etermination of NOS isoforms
Cells were infected or mock infected with HIV-1 and in
days the NO synthase activity was measured by mon-
toring the conversion of L-[3H]citrulline as previously
escribed (Obrego´n et al., 1997). Briefly, enzyme assays
ontained 25 ml of soluble tissue, 50 ml of 100 nM
3H]arginine and 1 mM NADPH, and 25 ml of 3 mM CaCl2.
fter a 15-min incubation at room temperature, the reac-
ion was stopped by addition of 3 ml of 20 mM HEPES
pH 5.5) containing 2 mM EDTA. The reaction mixtures
ere then applied to 0.5 ml Dowex AG50WX8 (Na1 form)
olumns. [3H]Citrulline was quantified by liquid scintilla-
ion spectroscopy of the 3-ml flow-through.
In addition, determination of NOS isoforms was car-
ied out by RT–PCR. Cells infected or not (105/ml) were
ncubated in RPMI 1640 supplemented with 5% (v/v) FCS
n Eppendorf tubes in the presence or the absence of
NF-a. At the indicated times cells were washed in PBS
nd the pellet was frozen at 270°C until further analysis.
he mRNA from 105 cells was isolated with oligo(dT)-
oated magnetic beads and subsequent reverse tran-
cription (PolyAtract Series 9600, Promega Corp., Madi-
on, WI), according to the manufacturer’s instructions.
or amplification of the desired cDNA, the following
ene-specific primers were used: iNOS sense (59-CCA-
AAGCAGAATGTGACCA-39) and iNOS antisense (59-TA-
ATGCTGGAGCCAAGGCCAAA-39) (Geller et al., 1993).
1he reaction mixture contained 5 ml cDNA (6 of the
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203HIV INDUCES NEURONAL DIFFERENTIATION VIA TNF AND iNOSsolated cDNA), 1 mM sense and antisense primers, 200
M deoxynucleotide triphosphates, and 2.5 U Taq DNA
olymerase (Perkin–Elmer) in a final volume of 50 ml. The
ycle program was set to denature at 94°C for 45 s, to
nneal at 58°C for 45 s, and to extend at 72°C for 2 min
or a total of 40 cycles. Electrophoresis of the PCR prod-
cts was performed on 1.5% agarose gels (FMC Bioprod-
cts, Rockland U.S.A.) containing 1 mg/ml ethidium bro-
ide.
lasmids and transient transfection assays
pBHluc 1.3, a luciferase plasmid containing 1.3 kbp of
he ICAM-1 59 flanking region (Voraberger et al., 1991),
as kindly provided by Dr. C. Stratowa. The reporter
NF-kB-luc expression vector contains three tandem
opies of the NF-kB site of the conalbumin promoter
riving the luciferase reporter gene and was provided by
r. J. Alcami (Alcami et al., 1995). SK-N-SH and SK-N-MC
ells (5 3 105) were plated at near confluence on 60-mm
ulture dishes and 24 h later were transfixed in OPTI-
EM medium (Life Technologies) containing 3 mg of
ipofectin (Life Technologies) and 1 mg of plasmid DNA
BHluc 1.3 for 24 h. After removal of the lipofectin-con-
aining transfection mixture, cells were resuspended in
ompleted medium and incubated at 37°C for 24 h. Then
ransfected cells were exposed to different stimuli for 4 h,
nd luciferase activity was measured according to the
nstructions of a luciferase system kit (Promega Corp.).
he light emission was measured for 30 s in the lumi-
ometer (Monolight 2010, Analitical Luminescence Lab-
ratory).
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